AXIM Biotechnologies, Inc.
AXIM
$0.003
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 93.00K | 85.40K | 39.80K | 34.50K | 26.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.00K | 85.40K | 39.80K | 34.50K | 26.20K |
| Cost of Revenue | 1.70K | -- | -- | -- | -- |
| Gross Profit | 91.20K | 85.40K | 39.80K | 34.50K | 26.20K |
| SG&A Expenses | 1.89M | 1.98M | 2.24M | 2.61M | 3.34M |
| Depreciation & Amortization | 429.70K | 428.40K | 427.20K | 427.20K | 427.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.41M | 2.53M | 2.79M | 3.17M | 3.89M |
| Operating Income | -2.32M | -2.44M | -2.75M | -3.14M | -3.87M |
| Income Before Tax | -4.14M | -5.59M | -8.06M | -7.06M | -9.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.14 | -5.59 | -8.06 | -7.06 | -9.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.14M | -5.59M | -8.06M | -7.06M | -9.42M |
| EBIT | -2.32M | -2.44M | -2.75M | -3.14M | -3.87M |
| EBITDA | -1.89M | -2.02M | -2.32M | -2.71M | -3.44M |
| EPS Basic | -0.02 | -0.02 | -0.04 | -0.03 | -0.05 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 |
| EPS Diluted | -0.02 | -0.03 | -0.05 | -0.04 | -0.05 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 1.02B | 958.49M | 911.59M | 860.72M | 800.25M |
| Average Diluted Shares Outstanding | 1.27B | 1.20B | 1.16B | 1.11B | 800.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
